Your browser doesn't support javascript.
loading
Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A.
Elnenaei, Manal O; Gruszka-Westwood, Alicja M; A'Hernt, Roger; Matutes, Estella; Sirohi, Bhawna; Powles, Ray; Catovsky, Daniel.
Affiliation
  • Elnenaei MO; Academic Department of Haematology and Cytogenetics, The Institute of Cancer Research and Royal Marsden Hospital Trust, 203 Fulham Road, London SW3 6JJ, UK.
Haematologica ; 88(5): 529-37, 2003 May.
Article in En | MEDLINE | ID: mdl-12745272
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Tumor Suppressor Protein p53 / Proto-Oncogene Proteins / Cyclin-Dependent Kinase Inhibitor p16 / Multiple Myeloma / Mutation Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2003 Document type: Article Affiliation country: United kingdom Country of publication: Italy
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Tumor Suppressor Protein p53 / Proto-Oncogene Proteins / Cyclin-Dependent Kinase Inhibitor p16 / Multiple Myeloma / Mutation Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2003 Document type: Article Affiliation country: United kingdom Country of publication: Italy